BioNTech SE (NASDAQ:BNTX) is one of the top high growth international stocks to buy right now. On September 10, BMO Capital analyst Evan Seigerman maintained a Buy rating on BioNTech SE (NASDAQ:BNTX), keeping the price target at $143.00.
The analyst stated that one of the primary reasons behind the optimistic rating is the anticipation of a stable COVID-19 vaccine business for BioNTech SE in the near and medium term, potentially providing a strong revenue base.
Seigerman added that BioNTech SE has an emerging pipeline with a number of catalysts that have the potential to drive share price appreciation, suggesting future growth.
BioNTech SE is a German biotechnology company that creates messenger RNA (mRNA) therapeutics and vaccines to address serious diseases such as cancer and infectious diseases. It specializes in developing and manufacturing immunotherapies for patient-specific approaches.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
